For citations:

Markova A.S., Matveev V.B. ANDROGEN DEPRIVATION THERAPY WITH LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONISTS FOR PROSTATE CANCER: BEST DISEASE CONTROL WITH A LOWER RISK OF SIDE EFFECTS. RESULTS OF ANALYSIS OF 6 COMPARATIVE RANDOMIZED PHASE III TRIALS OF DEGARELIX AND LUTEINIZIN. Cancer Urology. 2014;10(1):76-81. (In Russ.) https://doi.org/10.17650/1726-9776-2014-10-1-76-81